Hedge Fund - Copernicus Capital Management

Manager biography is currently missing.

Fund Profile

Filing Period:

Fund Name:	Copernicus Capital Management
Manager	John W. Rende
Portfolio Value	$8,263,000
Change This QTR	+1.30%

Top 13F Holdings

Filing Period:

Last updated on November 15, 2021 based on SEC 13F filings Last update: November 15, 2021

No.	Security	Ticker	Shares	Value (x$1000)	Activity	% Port
1.	Pfizer Inc	PFE	30,000	$1,290	NEW	15.61%
2.	Thermo Fisher Scientific Inc.	TMO	2,000	$1,143	NEW	13.83%
3.	Teladoc Health Inc.	TDOC	7,000	$888	NEW	10.74%
4.	Biomarin Pharmaceutical Inc	BMRN	11,000	$850	NEW	10.28%
5.	Johnson & Johnson	JNJ	5,000	$808	NEW	9.77%